[go: up one dir, main page]

CN111499528A - Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate by using terbutaline sulfate intermediate - Google Patents

Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate by using terbutaline sulfate intermediate Download PDF

Info

Publication number
CN111499528A
CN111499528A CN202010350331.3A CN202010350331A CN111499528A CN 111499528 A CN111499528 A CN 111499528A CN 202010350331 A CN202010350331 A CN 202010350331A CN 111499528 A CN111499528 A CN 111499528A
Authority
CN
China
Prior art keywords
compound
terbutaline sulfate
formula
solution
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010350331.3A
Other languages
Chinese (zh)
Other versions
CN111499528B (en
Inventor
杨远云
张弘
郑阳
杨柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Lier Pharmaceutical Co ltd
Original Assignee
Chengdu Ruiteen Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Ruiteen Technology Co ltd filed Critical Chengdu Ruiteen Technology Co ltd
Priority to CN202010350331.3A priority Critical patent/CN111499528B/en
Publication of CN111499528A publication Critical patent/CN111499528A/en
Application granted granted Critical
Publication of CN111499528B publication Critical patent/CN111499528B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a terbutaline sulfate intermediate, a preparation method thereof and a method for preparing terbutaline sulfate by using the terbutaline sulfate intermediate, and belongs to the technical field of medical chemistry. The invention aims to provide a method for preparing a compound of a compoundA new method for preparing terbutaline sulfate with high efficiency and environmental protection is provided, firstly, a terbutaline sulfate intermediate shown in formula I is provided; then, the terbutaline sulfate in the formula II is obtained by hydrogenation reduction with 10% Pd/C as a catalyst and an alcohol-water solution as a solvent. The free base hydrochloride or hydrobromide of the formula I is converted into the formula I before hydrogenation reduction, and then directly obtains the terbutaline sulfate after hydrogenation reduction, so that the independent occurrence of extremely unstable terbutaline free alkali is avoided, and the method has the advantages of mild reaction conditions, high product yield, high purity, low production cost and the like, and is beneficial to realizing industrial production.
Figure DDA0002471605150000011

Description

硫酸特布他林中间体及其制备方法和利用其制备硫酸特布他 林的方法Terbutaline sulfate intermediate and preparation method thereof and method for preparing terbutaline sulfate by using the same

技术领域technical field

本发明属于医药化学技术领域,具体涉及一种硫酸特布他林中间体及其制备方法和利用其制备硫酸特布他林的方法。The invention belongs to the technical field of medicinal chemistry, and particularly relates to a terbutaline sulfate intermediate and a preparation method thereof, and a method for preparing terbutaline sulfate by using the same.

背景技术Background technique

特布他林(terbutaline)化学名为1-(3,5-二羟基苯基)-2-叔丁氨基乙醇,是一种肾上腺素β2受体(β2受体)激动药,是目前平喘的主要药物之一。该药对β2受体具有高度选择性,心脏副作用小,适用于伴有高血压、冠心病等心血管疾病的哮喘病人。具有疗效高、起效快、作用时间长、副作用小等优点。β2受体激动药的临床应用以吸入治疗为首选,是轻、中度哮喘病人颇为有效的方法,副作用小。Terbutaline, chemically named 1-(3,5-dihydroxyphenyl)-2-tert-butylaminoethanol, is an adrenergic β2 receptor (β2 receptor) agonist. one of the main drugs. The drug is highly selective for β2 receptors and has few cardiac side effects, and is suitable for asthma patients with cardiovascular diseases such as hypertension and coronary heart disease. It has the advantages of high curative effect, fast onset, long action time and small side effects. Inhalation therapy is the first choice for clinical application of β2-receptor agonists, which are quite effective for mild and moderate asthma patients with less side effects.

根据国内外文献调研,特布他林的合成方法主要是:由3,5-二乙酰氧基苯乙酮或3,5-二苄氧基苯乙酮为原料,经溴化得到2-溴代-3,5-二乙酰氧基苯乙酮或2-溴代-3,5-二苄氧基苯乙酮,再与N-苄基叔丁胺胺化缩合得到2-N-苄基叔丁胺基-3,5-二乙酰氧基苯乙酮或2-N-苄基叔丁胺基-3,5-二苄氧基苯乙酮,最后经10%的Pd-C加压氢解脫苄和还原羰基或采用硼氢化钠还原羰基得2-叔丁胺基-1-(3,5-二乙酰氧基苯基)乙醇或2-叔丁胺基-1-(3,5-二羟基苯基)乙醇,2-叔丁胺基-1-(3,5-二乙酰氧基苯基)乙醇经氢溴酸水解得2-叔丁胺基-1-(3,5-二羟基苯基)乙醇。上述方法涉及的主要反应式为:According to domestic and foreign literature research, the synthesis method of terbutaline is mainly: from 3,5-diacetoxyacetophenone or 3,5-dibenzyloxyacetophenone as raw material, bromination to obtain 2-bromo Substituted-3,5-diacetoxyacetophenone or 2-bromo-3,5-dibenzyloxyacetophenone, and then aminated and condensed with N-benzyl-tert-butylamine to obtain 2-N-benzyl-tert-butylamine -3,5-Diacetoxyacetophenone or 2-N-benzyl-tert-butylamino-3,5-dibenzyloxyacetophenone, finally debenzyl and carbonyl reduction by 10% Pd-C pressurized hydrogenolysis Or use sodium borohydride to reduce carbonyl to obtain 2-tert-butylamino-1-(3,5-diacetoxyphenyl)ethanol or 2-tert-butylamino-1-(3,5-dihydroxyphenyl)ethanol, 2- Tert-butylamino-1-(3,5-diacetoxyphenyl)ethanol is hydrolyzed with hydrobromic acid to obtain 2-tert-butylamino-1-(3,5-dihydroxyphenyl)ethanol. The main reaction formula involved in the above method is:

Figure BDA0002471605130000011
Figure BDA0002471605130000011

Figure BDA0002471605130000021
Figure BDA0002471605130000021

上述的合成方法主要存在以下缺点:第一,需要在反应釜中进行高压反应,对安全性要求高;第二,用硼氢化钠还原羰基虽然可以避免加压反应,但还原后的反应液后处理困难;由于硼氢化钠还原羰基后产生的硼酸盐和特布他林游离碱或游离碱与酸所形成的盐其水溶性均特别好,因此想要将其从水溶液中分离出来比较困难;第三,采用“先还原-后成硫酸盐”的方式,还原条件较苛刻,特布他林游离碱提取难度大,且游离碱性质极不稳定,导致产品质量及收率下降;第四,反应需要采用氯仿、苯等一类有机溶剂。The above-mentioned synthetic method mainly has the following shortcomings: first, it is necessary to carry out high-pressure reaction in the reactor, and the safety requirements are high; second, although the reduction of carbonyl with sodium borohydride can avoid the pressure reaction, after the reduced reaction solution Difficult to handle; because the borate and terbutaline free base or the salt formed by the free base and acid produced by sodium borohydride reduction of carbonyl group are particularly water-soluble, so it is difficult to separate them from the aqueous solution ; Third, the method of "reduction first - sulfate later" is adopted, the reduction conditions are more severe, the extraction of terbutaline free base is difficult, and the properties of the free base are extremely unstable, resulting in a decline in product quality and yield; fourth , the reaction needs to use a class of organic solvents such as chloroform and benzene.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种反应条件温和、收率高、绿色环保的硫酸特布他林制备新方法。The object of the present invention is to provide a new method for preparing terbutaline sulfate with mild reaction conditions, high yield and environmental protection.

基于上述目的,本发明首先提供了一种硫酸特布他林中间体,其结构式如式I所示:Based on the above object, the present invention first provides a kind of terbutaline sulfate intermediate, and its structural formula is as shown in formula I:

Figure BDA0002471605130000022
Figure BDA0002471605130000022

其中,R为H或苄基。wherein R is H or benzyl.

本申请进一步提供了上述硫酸特布他林中间体的制备方法,其合成路线如下:The application further provides the preparation method of above-mentioned terbutaline sulfate intermediate, and its synthetic route is as follows:

Figure BDA0002471605130000023
Figure BDA0002471605130000023

其中,R’为乙酰基或苄基;当R’为乙酰基时,R为H,当R’为苄基时,R为苄基;Wherein, R' is acetyl or benzyl; When R' is acetyl, R is H, when R' is benzyl, R is benzyl;

包括以下步骤:Include the following steps:

A、化合物1与溴素反应,得化合物2;A, compound 1 reacts with bromine to obtain compound 2;

B、化合物2与化合物3反应,反应完毕,经回收溶剂后,得残余物;B, compound 2 reacts with compound 3, and the reaction is completed, and after recovering the solvent, a residue is obtained;

当R’为乙酰基时,残余物用盐酸或氢溴酸提取,酸水提取液经加热水解,冷却过滤,得化合物4盐酸盐或氢溴酸盐(即2-苄基叔丁胺基-1-(3,5二羟基)苯乙酮盐酸盐或氢溴酸盐);When R' is acetyl, the residue is extracted with hydrochloric acid or hydrobromic acid, the acid water extract is hydrolyzed by heating, cooled and filtered to obtain compound 4 hydrochloride or hydrobromide (ie 2-benzyl tert-butylamino-1 -(3,5 dihydroxy)acetophenone hydrochloride or hydrobromide);

当R’为苄基时,残余物加入有机溶剂,再用盐酸或氢溴酸提取,合并酸水层,得化合物4盐酸盐或氢溴酸盐水溶液(即2-苄基叔丁胺基-1-(3,5二苄氧基)苯乙酮盐酸盐或氢溴酸盐水溶液);When R' is benzyl, organic solvent is added to the residue, extracted with hydrochloric acid or hydrobromic acid, and the aqueous acid layers are combined to obtain compound 4 as an aqueous solution of hydrochloride or hydrobromide (ie, 2-benzyl-tert-butylamino-1 -(3,5dibenzyloxy)acetophenone hydrochloride or hydrobromide aqueous solution);

C、将化合物4配成水和有机溶剂的混合溶液,经碱化游离后,分得有机层,再向有机层加入硫酸成盐,得式I化合物。C. Compound 4 is made into a mixed solution of water and an organic solvent, and after alkalization is freed, an organic layer is obtained, and sulfuric acid is added to the organic layer to form a salt to obtain the compound of formula I.

其中,上述硫酸特布他林中间体的制备方法,步骤A中,化合物1与溴素的摩尔比为1:1~1.3。Wherein, in the above-mentioned preparation method of terbutaline sulfate intermediate, in step A, the molar ratio of compound 1 and bromine is 1:1-1.3.

其中,上述硫酸特布他林中间体的制备方法,步骤A的具体操作为:将化合物1溶于二氯甲烷,向其中滴加少量溴素-二氯甲烷溶液引发反应,然后冷却至10℃以下继续滴加溴素-二氯甲烷液,滴加完毕后,反应液经水洗涤、浓缩,无水乙醇结晶,得化合物2。Wherein, in the preparation method of the above-mentioned terbutaline sulfate intermediate, the specific operation of step A is as follows: compound 1 is dissolved in dichloromethane, a small amount of bromine-dichloromethane solution is added dropwise to it to initiate the reaction, and then cooled to 10° C. The bromine-dichloromethane solution is continued to be added dropwise below, and after the dropwise addition, the reaction solution is washed with water, concentrated, and crystallized from anhydrous ethanol to obtain compound 2.

其中,上述硫酸特布他林中间体的制备方法,步骤B中,化合物2与化合物3的摩尔比1:2~3。Wherein, in the above-mentioned preparation method of terbutaline sulfate intermediate, in step B, the molar ratio of compound 2 and compound 3 is 1:2-3.

其中,上述硫酸特布他林中间体的制备方法,步骤B中,化合物2与化合物3的反应条件为:以酮为溶剂,回流反应2~4h。Wherein, in the above-mentioned preparation method of the terbutaline sulfate intermediate, in step B, the reaction conditions of compound 2 and compound 3 are as follows: using ketone as a solvent, and performing a reflux reaction for 2-4 hours.

优选的,上述硫酸特布他林中间体的制备方法,步骤B中,所述酮为丁酮、2-戊酮、甲基异丙基甲酮或甲基叔丁基酮中的至少一种。Preferably, in the preparation method of the above-mentioned terbutaline sulfate intermediate, in step B, the ketone is at least one of butanone, 2-pentanone, methyl isopropyl ketone or methyl tert-butyl ketone .

更优选的,上述硫酸特布他林中间体的制备方法,步骤B中,所述酮为丁酮。More preferably, in the above-mentioned preparation method of terbutaline sulfate intermediate, in step B, the ketone is butanone.

其中,上述硫酸特布他林中间体的制备方法,步骤B中,盐酸或氢溴酸的浓度为0.5mol~1.5mol/L,采用薄层法监控提取是否完全。Wherein, in the above-mentioned preparation method of terbutaline sulfate intermediate, in step B, the concentration of hydrochloric acid or hydrobromic acid is 0.5mol-1.5mol/L, and the thin-layer method is used to monitor whether the extraction is complete.

其中,上述硫酸特布他林中间体的制备方法,步骤B中,当R’为乙酰基时,所述加热水解的条件为:30~60℃保温反应,水解终点采用薄层方法监控。Wherein, in the preparation method of the above-mentioned terbutaline sulfate intermediate, in step B, when R' is an acetyl group, the conditions for the heating and hydrolysis are: 30~60 ℃ thermal insulation reaction, and the end point of the hydrolysis is monitored by a thin layer method.

其中,上述硫酸特布他林中间体的制备方法,步骤C中,碱化游离的条件为:碱化至至反应液pH为8~9,所述碱为碳酸钠、碳酸钾、氢氧化钠或氢氧化钾中的至少一种。Wherein, in the preparation method of the above-mentioned terbutaline sulfate intermediate, in step C, the conditions for alkalization and disassociation are: alkalization until the pH of the reaction solution is 8-9, and the alkali is sodium carbonate, potassium carbonate, and sodium hydroxide or at least one of potassium hydroxide.

优选的,上述硫酸特布他林中间体的制备方法,步骤C中,所述碱为碳酸钠或碳酸钾。Preferably, in the preparation method of the above-mentioned terbutaline sulfate intermediate, in step C, the alkali is sodium carbonate or potassium carbonate.

其中,上述硫酸特布他林中间体的制备方法,步骤C中,硫酸成盐的条件为:硫酸调节有机层pH至5±0.2。Wherein, in the above-mentioned preparation method of terbutaline sulfate intermediate, in step C, the conditions for sulfuric acid salification are: sulfuric acid adjusts the pH of the organic layer to 5±0.2.

本发明进一步利用上述方法制备所得硫酸特布他林中间体制备硫酸特布他林的方法,其合成路线如下:The present invention further utilizes the method for preparing the obtained terbutaline sulfate intermediate to prepare the terbutaline sulfate by the above-mentioned method, and its synthetic route is as follows:

Figure BDA0002471605130000041
Figure BDA0002471605130000041

其中,R为H或苄基;Wherein, R is H or benzyl;

包括以下步骤:以10%Pd/C为催化剂,醇水溶液为溶剂,通入H2,将式I硫酸特布他林中间体还原,得式II硫酸特布他林。The method comprises the following steps: using 10% Pd/C as a catalyst, an aqueous alcohol solution as a solvent, and introducing H 2 to reduce the intermediate of formula I terbutaline sulfate to obtain terbutaline sulfate of formula II.

其中,上述的制备硫酸特布他林的方法中,式I化合物与10%Pd/C的质量比为1:0.02~0.1。Wherein, in the above-mentioned method for preparing terbutaline sulfate, the mass ratio of the compound of formula I to 10% Pd/C is 1:0.02-0.1.

优选的,上述的制备硫酸特布他林的方法中,式I化合物与10%Pd/C的质量比为1:0.03~0.05。Preferably, in the above-mentioned method for preparing terbutaline sulfate, the mass ratio of the compound of formula I to 10% Pd/C is 1:0.03-0.05.

其中,上述的制备硫酸特布他林的方法中,醇水溶液为含量50%~95%的甲醇水溶液或乙醇水溶液。Wherein, in the above-mentioned method for preparing terbutaline sulfate, the aqueous alcohol solution is an aqueous methanol solution or an aqueous ethanol solution with a content of 50% to 95%.

优选的,上述的制备硫酸特布他林的方法中,醇水溶液为60%~90%的甲醇水溶液或乙醇水溶液。Preferably, in the above-mentioned method for preparing terbutaline sulfate, the aqueous alcohol solution is a 60% to 90% aqueous methanol solution or an aqueous ethanol solution.

其中,上述的制备硫酸特布他林的方法中,式I化合物与醇水溶液的用量比为1g:10~20mL。Wherein, in the above-mentioned method for preparing terbutaline sulfate, the dosage ratio of the compound of formula I to the aqueous alcohol solution is 1 g: 10-20 mL.

优选的,上述的制备硫酸特布他林的方法中,式I化合物与醇水溶液的用量比为1g:15mL。Preferably, in the above-mentioned method for preparing terbutaline sulfate, the dosage ratio of the compound of formula I to the aqueous alcohol solution is 1 g: 15 mL.

其中,上述的制备硫酸特布他林的方法中,氢化还原温度为15~50℃。Wherein, in the above-mentioned method for preparing terbutaline sulfate, the hydrogenation reduction temperature is 15-50°C.

优选的,上述的制备硫酸特布他林的方法中,氢化还原温度为15~35℃。Preferably, in the above-mentioned method for preparing terbutaline sulfate, the hydrogenation reduction temperature is 15-35°C.

其中,上述的制备硫酸特布他林的方法中,氢化还原压力为常压~0.5Mpa。Wherein, in the above-mentioned method for preparing terbutaline sulfate, the hydrogenation reduction pressure is normal pressure~0.5Mpa.

优选的,上述的制备硫酸特布他林的方法中,氢化还原压力为常压~0.2Mpa。Preferably, in the above-mentioned method for preparing terbutaline sulfate, the hydrogenation reduction pressure is normal pressure~0.2Mpa.

本发明的有益效果:Beneficial effects of the present invention:

本发明将化合物4在氢化还原之前转化为式I,其优点:1、盐性质稳定,氢化还原后直接得到特布他林硫酸盐,其后处理比较简单,无需氢化后再成盐,避免了极不稳定的特布他林游离碱单独出现导致的产品质量及收率下降;2、反应条件温和:可以在常温常压下氢化还原,且反应时间短;3、收率高,氢化还原收率在90~98%,硫酸特布他林单杂均在0.1%以下;4、钯炭加入量减少为主药量的3~5%(文献为10%),降低产品成本;5、避免了一类有机溶剂的使用。In the present invention, compound 4 is converted into formula I before hydrogenation reduction, and its advantages are: 1. The salt properties are stable, and terbutaline sulfate is directly obtained after hydrogenation reduction. The extremely unstable terbutaline free base alone causes the product quality and yield to decline; 2. The reaction conditions are mild: hydrogenation reduction can be performed at normal temperature and pressure, and the reaction time is short; 3. The yield is high, and the hydrogenation reduction yields The rate is 90-98%, and the terbutaline sulfate is less than 0.1%; 4. The amount of palladium carbon added is reduced by 3-5% of the main drug (10% in the literature), reducing product cost; 5. Avoid The use of a class of organic solvents.

本发明方法具有反应条件温和、产品收率高、纯度高、生产成本低等优点,完全符合工业生产要求,具有推广价值。The method of the invention has the advantages of mild reaction conditions, high product yield, high purity, low production cost and the like, fully meets the requirements of industrial production, and has popularization value.

附图说明Description of drawings

图1为式I化合物(R为H)核磁共振碳谱图。Fig. 1 is the carbon nuclear magnetic resonance spectrum of the compound of formula I (R is H).

图2为式I化合物(R为H)核磁共振氢谱图。Figure 2 is a hydrogen nuclear magnetic resonance spectrum of the compound of formula I (R is H).

图3为硫酸特布他林红外图谱。Figure 3 is an infrared spectrum of terbutaline sulfate.

图4为硫酸特布他林碳谱图。Figure 4 is a carbon spectrum of terbutaline sulfate.

图5为硫酸特布他林氢谱图。Figure 5 is a hydrogen spectrum of terbutaline sulfate.

图6为实施例17精制硫酸特布他林的HPLC检测图。6 is the HPLC detection chart of the purified terbutaline sulfate in Example 17.

图7为实施例18精制硫酸特布他林的HPLC检测图。Fig. 7 is the HPLC detection chart of purified terbutaline sulfate in Example 18.

图8为实施例19精制硫酸特布他林的HPLC检测图。Fig. 8 is the HPLC detection chart of purified terbutaline sulfate in Example 19.

具体实施方式Detailed ways

发明人试验发现:化合物4盐酸盐或氢溴酸盐,比较稳定,按文献方法用化合物4盐酸盐或氢溴酸盐在35℃、0.5Mpa来氢化还原,苄基易于氢解,但羰基难以还原,将温度升至50℃,压力升至1.2~1.5Mpa,氢化完成也需要15小时以上,收率一般在70%左右;同时还原后,特布他林游离碱(base)水溶性极大,根本无法从水中提取出来,而且游离碱性质极不稳定,室温放置过程中极易氧化变色,导致产品质量及收率下降。因此本发明经过大量尝试,在氢化还原之前,将化合物4盐酸盐或氢溴酸盐转化为式I,避免上述情况,并在更优异的情况下获得硫酸特布他林。The inventor's experiments found that: Compound 4 hydrochloride or hydrobromide is relatively stable. According to the literature method, compound 4 hydrochloride or hydrobromide is used for hydrogenation reduction at 35 ° C and 0.5Mpa, and the benzyl group is easy to hydrogenolysis, but The carbonyl group is difficult to reduce, the temperature is raised to 50°C, the pressure is raised to 1.2-1.5Mpa, and it takes more than 15 hours to complete the hydrogenation, and the yield is generally about 70%; at the same time, the free base of terbutaline is water-soluble. It is extremely large and cannot be extracted from water at all, and the free base is extremely unstable, and it is easily oxidized and discolored during storage at room temperature, resulting in a decrease in product quality and yield. Therefore, after a lot of attempts in the present invention, before hydrogenation reduction, compound 4 hydrochloride or hydrobromide is converted into formula I, so as to avoid the above situation, and obtain terbutaline sulfate in a more excellent situation.

具体的,硫酸特布他林中间体,其结构式如式I所示:Concrete, terbutaline sulfate intermediate, its structural formula is as shown in formula I:

Figure BDA0002471605130000051
Figure BDA0002471605130000051

其中,R为H或苄基。wherein R is H or benzyl.

本申请进一步提供了上述硫酸特布他林中间体的制备方法,其合成路线如下:The application further provides the preparation method of above-mentioned terbutaline sulfate intermediate, and its synthetic route is as follows:

Figure BDA0002471605130000061
Figure BDA0002471605130000061

其中,R’为乙酰基或苄基;当R’为乙酰基时,R为H,当R’为苄基时,R为苄基;Wherein, R' is acetyl or benzyl; When R' is acetyl, R is H, when R' is benzyl, R is benzyl;

包括以下步骤:Include the following steps:

A、化合物1与溴素反应,得化合物2;A, compound 1 reacts with bromine to obtain compound 2;

B、化合物2与化合物3反应,反应完毕,经回收溶剂后,得残余物;B, compound 2 reacts with compound 3, and the reaction is completed, and after recovering the solvent, a residue is obtained;

当R’为乙酰基时,残余物用盐酸或氢溴酸提取,酸水提取液经加热水解,冷却过滤干燥,得化合物4盐酸盐或氢溴酸盐;When R' is an acetyl group, the residue is extracted with hydrochloric acid or hydrobromic acid, the acid water extract is hydrolyzed by heating, cooled, filtered and dried to obtain compound 4 hydrochloride or hydrobromide;

当R’为苄基时,残余物加入有机溶剂,然后用盐酸或氢溴酸提取,合并酸水层,得化合物4盐酸盐或氢溴酸盐的水溶液;When R' is benzyl, the residue is added with an organic solvent, then extracted with hydrochloric acid or hydrobromic acid, and the acid water layers are combined to obtain an aqueous solution of compound 4 hydrochloride or hydrobromide;

C、将化合物4配成水和有机溶剂的混合溶液,经碱化游离后,分得有机层,再向有机层加入硫酸成盐,得式I化合物。C. Compound 4 is made into a mixed solution of water and an organic solvent, and after alkalization is freed, an organic layer is obtained, and sulfuric acid is added to the organic layer to form a salt to obtain the compound of formula I.

步骤A中,化合物1与溴素的摩尔比为1:1~1.3;具体操作为:将化合物1溶于二氯甲烷,向其中滴加少量溴素-二氯甲烷溶液引发反应,然后冷却至10℃以下继续滴加溴素-二氯甲烷液,滴加完毕后,反应液经水洗涤、浓缩,无水乙醇结晶,得化合物2,溴化收率为78~86%。In step A, the molar ratio of compound 1 to bromine is 1:1 to 1.3; the specific operation is as follows: compound 1 is dissolved in dichloromethane, a small amount of bromine-dichloromethane solution is added dropwise to it to initiate the reaction, and then cooled to The bromine-dichloromethane solution was continued to be added dropwise below 10°C. After the dropwise addition, the reaction solution was washed with water, concentrated, and crystallized from anhydrous ethanol to obtain compound 2 with a bromination yield of 78-86%.

步骤B中,化合物2与化合物3的摩尔比1:2~3;化合物2与化合物3的反应条件为:以酮为溶剂,回流反应2~4h。酮可以是丁酮、2-戊酮、甲基异丙基甲酮、甲基叔丁基酮,优选丁酮。In step B, the molar ratio of compound 2 to compound 3 is 1:2 to 3; the reaction conditions of compound 2 and compound 3 are as follows: using ketone as a solvent, the reaction is refluxed for 2 to 4 hours. The ketone may be butanone, 2-pentanone, methyl isopropyl ketone, methyl tert-butyl ketone, preferably butanone.

步骤B中,发明人曾尝试直接采用硫酸提取残留物,以制备式I,但所得式I化合物收率低且质量差,因此未采用硫酸提取水解法。步骤B中,盐酸或氢溴酸的浓度为0.5mol~1.5mol/L,采用薄层法监控提取是否完全(薄层条件为:硅胶GF254薄层板,展开剂为二氯甲烷:乙酸乙酯:三乙胺体积比10:1:0.4,紫外灯254nm显色)。In step B, the inventors have tried to directly extract the residue with sulfuric acid to prepare formula I, but the obtained compound of formula I has low yield and poor quality, so the sulfuric acid extraction and hydrolysis method is not used. In step B, the concentration of hydrochloric acid or hydrobromic acid is 0.5mol~1.5mol/L, adopt the thin layer method to monitor whether the extraction is complete (the thin layer condition is: silica gel GF254 thin layer plate, and the developing agent is dichloromethane: ethyl acetate) : triethylamine volume ratio 10:1:0.4, UV lamp 254nm color development).

步骤B中,酸提取后,根据取代基不同,酸水处理方式有所差异:当R’为乙酰基时,酸水提取液需要加热水解,以脱除乙酰基,加热水解的条件为30~60℃保温反应,水解终点采用薄层方法监控(薄层条件为:硅胶GF254薄层板,展开剂为二氯甲烷:乙酸乙酯:三乙胺体积比10:1:0.4,紫外灯254nm显色),反应完成后,冷却过滤,收集固体即化合物4(该化合物4在步骤C中需要加入水和有机溶剂,以便碱化游离和硫酸成盐);当R’为苄基时,合并酸水层,得化合物4盐酸盐或氢溴酸盐的水溶液(该水溶液在步骤C中需要加入有机溶剂,以便碱化游离和硫酸成盐)。步骤B中,缩合和水解两步收率为60~70%。In step B, after acid extraction, according to different substituents, the acid water treatment method is different: when R' is an acetyl group, the acid water extract needs to be heated and hydrolyzed to remove the acetyl group. The reaction was incubated at 60°C, and the end point of the hydrolysis was monitored by the thin-layer method (the thin-layer conditions were: silica gel GF254 thin-layer plate, the developing solvent was dichloromethane:ethyl acetate:triethylamine volume ratio of 10:1:0.4, and the UV lamp was displayed at 254 nm. color), after the reaction is completed, cool and filter, collect the solid compound 4 (this compound 4 needs to add water and an organic solvent in step C, so as to basify free and sulfuric acid into a salt); when R' is benzyl, combine the acid The aqueous layer is obtained to obtain an aqueous solution of compound 4 hydrochloride or hydrobromide (this aqueous solution needs to add an organic solvent in step C, so as to basify the free and sulfuric acid to form a salt). In step B, the yield of the two steps of condensation and hydrolysis is 60-70%.

步骤C中,碱化游离的条件为:加碱中和至反应液pH为8~9;然后分出有机层,无水硫酸钠脱水,硫酸成盐;硫酸成盐的条件为:硫酸调节有机层pH至5±0.2;硫酸成盐时,对pH要求需要较为精确,因此优选硫酸调节有机层pH至5。步骤C中,化合物4盐酸盐或氢溴酸盐转换为硫酸盐收率为95~98%。In step C, the conditions for alkalization and dissociation are: adding alkali to neutralize the pH of the reaction solution to 8 to 9; then separating the organic layer, dehydrating anhydrous sodium sulfate, and forming salts with sulfuric acid; The pH of the layer is to 5±0.2; when sulfuric acid is formed into a salt, the pH requirement needs to be more precise, so it is preferable to adjust the pH of the organic layer to 5 with sulfuric acid. In step C, the yield of compound 4 hydrochloride or hydrobromide converted to sulfate is 95-98%.

步骤B和C中,加入有机溶剂和水的目的是为了碱化时,式I游离碱即时提入有机层,而中和后产生的无机盐则溶解在水层之中,因此可根据实际反应和分离情况,控制水和有机溶剂的加入量。有机溶剂可以是乙酸乙酯、二氯甲烷、乙醚、异丙醚,优选乙酸乙酯。In steps B and C, the purpose of adding organic solvent and water is for alkalization, the free base of formula I is immediately introduced into the organic layer, and the inorganic salt produced after neutralization is dissolved in the water layer, so it can be reacted according to actual conditions. And the separation situation, control the amount of water and organic solvent added. The organic solvent can be ethyl acetate, dichloromethane, diethyl ether, isopropyl ether, preferably ethyl acetate.

本发明进一步利用上述方法制备所得硫酸特布他林中间体制备硫酸特布他林的方法,其合成路线如下:The present invention further utilizes the method for preparing the obtained terbutaline sulfate intermediate to prepare the terbutaline sulfate by the above-mentioned method, and its synthetic route is as follows:

Figure BDA0002471605130000071
Figure BDA0002471605130000071

其中,R为H或苄基;Wherein, R is H or benzyl;

包括以下步骤:以10%Pd/C为催化剂,醇水溶液为溶剂,通入H2,将式I硫酸特布他林中间体还原,得式II硫酸特布他林。The method comprises the following steps: using 10% Pd/C as a catalyst, an aqueous alcohol solution as a solvent, and introducing H 2 to reduce the intermediate of formula I terbutaline sulfate to obtain terbutaline sulfate of formula II.

上述制备硫酸特布他林的方法中,式I化合物与10%Pd/C的质量比为1:0.02~0.1,优选为1:0.03~0.05;醇水溶液为含量50%~95%的甲醇水溶液或乙醇水溶液,优选为60%~90%的甲醇水溶液或乙醇水溶液;式I化合物与醇水溶液的用量比为1g:10~20mL,优选为1g:15mL;还原温度为15~50℃,优选为15~35℃;还原压力为常压~0.5Mpa,优选为常压~0.2Mpa。该步骤中,TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂为二氯甲烷:甲醇:三乙胺体积比10:2:1,紫外灯254nm显色;氢化还原收率90~98%。In the above method for preparing terbutaline sulfate, the mass ratio of the compound of formula I to 10% Pd/C is 1:0.02-0.1, preferably 1:0.03-0.05; the aqueous alcohol solution is an aqueous methanol solution with a content of 50%-95% or ethanol aqueous solution, preferably 60%~90% methanol aqueous solution or ethanol aqueous solution; the dosage ratio of the compound of formula I to the alcoholic aqueous solution is 1g: 10~20mL, preferably 1g: 15mL; the reduction temperature is 15~50 ℃, preferably 15~35℃; the reduction pressure is normal pressure~0.5Mpa, preferably normal pressure~0.2Mpa. In this step, TLC is monitored until the hydrogenation reaction of the raw materials is complete, silica gel GF 254 , the developing solvent is dichloromethane:methanol:triethylamine volume ratio 10:2:1, UV lamp 254nm color development; hydrogenation reduction yield 90~98 %.

由上述可知,本发明采用式I还原制备硫酸特布他林,反应可以在常温常压下氢化还原,钯炭用量少,反应时间短,硫酸特布他林收率高达90~98%,精制后产品单杂均在0.1%以下,更有利于实现硫酸特布他林工业生产。As can be seen from the above, the present invention adopts formula I reduction to prepare terbutaline sulfate, the reaction can be hydrogenated and reduced at normal temperature and pressure, the amount of palladium carbon is small, the reaction time is short, and the yield of terbutaline sulfate is as high as 90-98%, The single-impurity average of the refined product is less than 0.1%, which is more conducive to realizing the industrial production of terbutaline sulfate.

硫酸特布他林粗品的精制步骤为:采用活性炭脱色、醇(甲醇或乙醇)结晶;精制收率为90~95%。The refining steps of the crude terbutaline sulfate are as follows: decolorization with activated carbon, crystallization from alcohol (methanol or ethanol); the refining yield is 90-95%.

下面通过实施例对本发明作进一步详细说明,但并不因此将本发明保护范围限制在所述的实施例范围之中。The present invention will be further described in detail below through the examples, but the protection scope of the present invention is not limited to the scope of the described examples.

实施例1:制备化合物2(R’为乙酰基)Example 1: Preparation of compound 2 (R' is acetyl)

向带有尾气吸收装置的反应瓶中加入76mL二氯甲烷和38g 3,5-二乙酰氧基苯乙酮,搅拌溶解完全后,室温下滴加数滴溴素-二氯甲烷混合液(溴素27g二氯甲烷27ml),保温搅拌至有酸性气体(用湿润的pH试纸检查)逸出时冷却至10℃以下,保温继续滴加溴素-二氯甲烷溶液,TLC监控原料斑点基本消失(薄层监控方法:硅胶GF254,展开剂:二氯甲烷-乙酸乙酯(10:1),紫外灯254nm显色),停止反应。用水洗涤反应液至水层pH为6~7,二氯甲烷层用无水硫酸镁干燥,过滤,减压蒸干溶剂,残留物加无水乙醇结晶,得41.6克化合物2,收率82%。76mL of dichloromethane and 38g of 3,5-diacetoxyacetophenone were added to the reaction flask with the tail gas absorption device, after stirring and dissolving completely, several drops of bromine-dichloromethane mixed solution (bromine) were added dropwise at room temperature. 27g of dichloromethane 27ml), keep stirring until there is acid gas (check with moist pH test paper) and cool to below 10°C when escaping, and keep adding bromine-dichloromethane solution dropwise, TLC monitoring raw material spots basically disappear ( TLC monitoring method: silica gel GF 254 , developing solvent: dichloromethane-ethyl acetate (10:1), UV lamp 254nm color development), stop the reaction. The reaction solution was washed with water until the pH of the aqueous layer was 6-7, the dichloromethane layer was dried over anhydrous magnesium sulfate, filtered, and the solvent was evaporated to dryness under reduced pressure. The residue was crystallized by adding anhydrous ethanol to obtain 41.6 g of compound 2 with a yield of 82%. .

实施例2:制备化合物2(R’为乙酰基)Example 2: Preparation of compound 2 (R' is acetyl)

向带有尾气吸收装置的反应瓶中加入236g3,5-二乙酰氧基苯乙酮及500mL二氯甲烷,搅拌溶解完全后,室温下滴加160g溴素与160ml二氯甲烷的溶液数滴,保温搅拌至有溴化氢气体(用湿润的pH试纸检查)逸出后,降温至10℃以下,继续滴加入溴素二氯甲烷溶液,TLC监控原料斑点基本消失(薄层监控方法:硅胶GF254,展开剂:二氯甲烷-乙酸乙酯(10:1),紫外灯254nm显色),水洗涤至pH6~7,有机层无水硫酸镁干燥,过滤,减压除尽溶剂,残余物加无水乙醇结晶,得化合物2,产量246g,收率78%。Add 236g of 3,5-diacetoxyacetophenone and 500mL of dichloromethane to the reaction flask with the tail gas absorption device, after stirring and dissolving completely, add a few drops of a solution of 160g of bromine and 160ml of dichloromethane at room temperature, Keep stirring until hydrogen bromide gas (check with wet pH test paper) escapes, cool down to below 10°C, continue to add bromine dichloromethane solution dropwise, TLC monitoring raw material spots basically disappear (thin layer monitoring method: silica gel GF 254 , developing solvent: dichloromethane-ethyl acetate (10:1), UV lamp 254nm color development), washed with water to pH 6-7, the organic layer was dried over anhydrous magnesium sulfate, filtered, and the solvent was removed under reduced pressure, the residue was Add anhydrous ethanol for crystallization to obtain compound 2, the yield is 246 g, and the yield is 78%.

实施例3:制备化合物2(R’为乙酰基)Example 3: Preparation of compound 2 (R' is acetyl)

向带有尾气吸收装置的反应瓶中加入236g3,5-二乙酰氧基苯乙酮及472mL二氯甲烷,搅拌溶解完全后,室温搅拌下滴加176g溴素和176mL二氯甲烷溶液数滴,待有溴化氢气体(用湿润的pH试纸检查)逸出后,降温至10℃以下,继续滴加入溴素二氯甲烷溶液,TLC监控原料斑点基本消失(薄层监控方法:硅胶GF254,展开剂:二氯甲烷-乙酸乙酯(10:1),紫外灯254nm显色),通氮气或空气排除溴化氢,水洗涤至pH6~7,有机层无水硫酸镁干燥,过滤,减压除尽溶剂,残余物加无水乙醇结晶,得化合物2,产量271g,收率86%。Add 236g of 3,5-diacetoxyacetophenone and 472mL of dichloromethane to the reaction flask with the tail gas absorption device, after stirring and dissolving completely, add 176g of bromine and 176mL of dichloromethane solution dropwise with stirring at room temperature. After hydrogen bromide gas (check with wet pH test paper) escapes, cool down to below 10°C, continue to add bromine dichloromethane solution dropwise, TLC monitoring raw material spots basically disappear (thin layer monitoring method: silica gel GF 254 , Developing solvent: dichloromethane-ethyl acetate (10:1), UV lamp 254nm color development), pass nitrogen or air to remove hydrogen bromide, wash with water to pH 6-7, dry the organic layer over anhydrous magnesium sulfate, filter, reduce The solvent was removed by pressure, and the residue was crystallized by adding anhydrous ethanol to obtain compound 2, the yield was 271 g, and the yield was 86%.

实施例4:制备化合物2(R’为苄基)Example 4: Preparation of compound 2 (R' is benzyl)

向带有尾气吸收装置的反应瓶中加入332g3,5-二苄氧基苯乙酮及665mL二氯甲烷,搅拌溶解完全后,室温搅拌下滴加165g溴素和165ml二氯甲烷溶液数滴,待有溴化氢气体(用湿润的pH试纸检查)逸出后,降温至10℃以下,继续滴加入溴素二氯甲烷溶液,TLC监控原料斑点基本消失(薄层监控方法:硅胶GF254,展开剂:二氯甲烷-乙酸乙酯(10:1),紫外灯254nm显色),通氮气或空气排除溴化氢,水洗涤至pH6~7,有机层无水硫酸镁干燥,过滤,减压除尽溶剂,残余物加无水乙醇结晶,得化合物2,产量329g,收率80%。Add 332g of 3,5-dibenzyloxyacetophenone and 665mL of dichloromethane to the reaction flask with the tail gas absorption device, after stirring and dissolving completely, add 165g of bromine and 165ml of dichloromethane solution dropwise with stirring at room temperature. After hydrogen bromide gas (check with wet pH test paper) escapes, cool down to below 10°C, continue to add bromine dichloromethane solution dropwise, TLC monitoring raw material spots basically disappear (thin layer monitoring method: silica gel GF 254 , Developing solvent: dichloromethane-ethyl acetate (10:1), UV lamp 254nm color development), pass nitrogen or air to remove hydrogen bromide, wash with water to pH 6-7, dry the organic layer over anhydrous magnesium sulfate, filter, reduce The solvent was removed by pressure, and the residue was crystallized by adding anhydrous ethanol to obtain compound 2, the yield was 329 g, and the yield was 80%.

实施例5:制备化合物4(R’为乙酰基)Example 5: Preparation of compound 4 (R' is acetyl)

将315g化合物2(R’为乙酰基)、400gN-苄基叔丁胺及3.5L丁酮加入反应瓶中,加热回流约2小时,薄层法监控监控反应是否完全(薄层条件为:硅胶GF254薄层板,展开剂:二氯甲烷-乙酸乙酯(10:1),冷却,过滤除去不溶物,减压回收丁酮,残余物用1mol/L盐酸提取2~3次,每次约800mL,薄层法监控提取是否完全(薄层条件为:硅胶GF254薄层板,展开剂:二氯甲烷-乙酸乙酯-三乙胺(10:1:0.4),紫外灯254nm显色)。合并酸水层,30℃保温约15小时,水解终点采用薄层方法监控(薄层条件同上),冷却过滤,干燥,得化合物4(盐酸盐,R为H)245g,收率70%。315g of compound 2 (R' is acetyl), 400g of N-benzyl tert-butylamine and 3.5L of butanone were added to the reaction flask, heated to reflux for about 2 hours, and the thin-layer method monitored and monitored whether the reaction was complete (the thin-layer conditions were: silica gel GF254 thin layer) Layer plate, developing solvent: dichloromethane-ethyl acetate (10:1), cooled, filtered to remove insoluble matter, recovered under reduced pressure, butanone, and the residue was extracted with 1 mol/L hydrochloric acid for 2 to 3 times, about 800 mL each time, Monitor whether the extraction is complete by thin-layer method (the thin-layer conditions are: silica gel GF254 thin-layer plate, developing solvent: dichloromethane-ethyl acetate-triethylamine (10:1:0.4), UV lamp 254nm color development). Combine acid The water layer was kept at 30°C for about 15 hours, the end point of the hydrolysis was monitored by the thin-layer method (the thin-layer conditions were the same as above), cooled, filtered, and dried to obtain 245 g of compound 4 (hydrochloride, R is H), with a yield of 70%.

实施例6:制备化合物4(R’为乙酰基)Example 6: Preparation of compound 4 (R' is acetyl)

将315g化合物2(R’为乙酰基)、326gN-苄基叔丁胺及3.5L丁酮加入反应瓶中,加热回流约3小时(薄层法监控提取是否完全,方法同上),冷却,过滤除去不溶物,减压回收丁酮,残余物用1mol/L盐酸提取2~3次,每次约800mL(薄层法监控提取是否完全,方法同上),合并酸水层,50℃保温约6小时,水解终点采用薄层方法监控(薄层条件同上),冷却过滤,干燥,得化合物4(盐酸盐,R为H)210g,收率60%。315g of compound 2 (R' is acetyl), 326g of N-benzyl tert-butylamine and 3.5L of butanone were added to the reaction flask, heated to reflux for about 3 hours (whether the extraction was complete by thin-layer method, the method was the same as above), cooled, filtered to remove insoluble The residue was extracted with 1 mol/L hydrochloric acid for 2 to 3 times, with about 800 mL each time (the thin-layer method was used to monitor whether the extraction was complete, the method was the same as above), the acid water layers were combined, and the temperature was kept at 50 °C for about 6 hours. The end point of hydrolysis was monitored by thin-layer method (the thin-layer conditions were the same as above), filtered by cooling, and dried to obtain 210 g of compound 4 (hydrochloride, R is H), with a yield of 60%.

实施例7:制备化合物4(R’为乙酰基)Example 7: Preparation of compound 4 (R' is acetyl)

将315g化合物2(R’为乙酰基)、450gN-苄基叔丁胺及3.5L丁酮加入反应瓶中,加热回流约3小时(薄层法监控反应是否完全,方法同上),冷却,过滤除去不溶物,减压回收丁酮,残余物用1mol/L氢溴酸提取2~3次(薄层法监控提取是否完全,方法同上),每次800mL,合并酸水层,55℃保温约3.5小时,水解终点采用薄层方法监控(薄层条件同上),冷却过滤,干燥,得化合物4(氢溴酸盐,R为H)267g,收率68%。315g of compound 2 (R' is acetyl), 450g of N-benzyl tert-butylamine and 3.5L of butanone were added to the reaction flask, heated to reflux for about 3 hours (whether the reaction was completed by thin-layer method, the method was the same as above), cooled, filtered to remove insoluble The residue was extracted with 1 mol/L hydrobromic acid for 2 to 3 times (the thin-layer method was used to monitor whether the extraction was complete, the method was the same as above), 800 mL each time, and the acid water layer was combined, and the temperature was kept at 55 °C for about 3.5 hours. , the end point of hydrolysis was monitored by thin-layer method (the thin-layer conditions were the same as above), cooled, filtered, and dried to obtain 267 g of compound 4 (hydrobromide salt, R is H), with a yield of 68%.

实施例8:制备式I化合物(R为H)Example 8: Preparation of compounds of formula I (R is H)

将55g实施例5所得化合物4(盐酸盐)及水250mL加入反应瓶中,加入250mL乙酸乙酯,搅拌下加入碳酸钠至pH8~9,分出有机层无水硫酸钠干燥,滴加入硫酸调pH5,过滤,干燥,得式I化合物(R为H)55.8g,收率98%。Add 55 g of compound 4 (hydrochloride) obtained in Example 5 and 250 mL of water into the reaction flask, add 250 mL of ethyl acetate, add sodium carbonate to pH 8-9 under stirring, separate the organic layer and dry with anhydrous sodium sulfate, and add dropwise sulfuric acid. The pH was adjusted to 5, filtered and dried to obtain 55.8 g of the compound of formula I (R is H) with a yield of 98%.

实施例9:制备式I化合物(R为H)Example 9: Preparation of compound of formula I (R is H)

将50g实施例7所得化合物4(氢溴酸盐)及水220mL加入反应瓶中,加入220mL乙酸乙酯,搅拌下加入碳酸钠至pH8~9,乙酸乙酯层经无水硫酸钠干燥,于室温搅拌下滴加入硫酸至pH5析出固体,过滤,干燥,得式I化合物(R为H)44.1g,收率96%。50 g of compound 4 (hydrobromide) obtained in Example 7 and 220 mL of water were added to the reaction flask, 220 mL of ethyl acetate was added, and sodium carbonate was added to pH 8 to 9 under stirring. Under stirring at room temperature, sulfuric acid was added dropwise to pH 5 to precipitate a solid, which was filtered and dried to obtain 44.1 g of the compound of formula I (R is H) with a yield of 96%.

实施例10:制备式I化合物(R为苄基)Example 10: Preparation of compounds of formula I (R is benzyl)

将41g化合物2(R’为苄基)、40gN-苄基叔丁胺及350mL丁酮加入反应瓶中,加热回流约3小时(薄层法监控反应是否完全,方法同上),冷却,过滤除去不溶物,减压回收丁酮,残余物加入200mL乙酸乙酯,用1mol/L氢溴酸提取2~3次(薄层法监控提取是否完全,方法同上),每次80mL,合并酸水层,得化合物4的氢溴酸水溶液(R为苄基);向其中加入乙酸乙酯300mL,搅拌下用碳酸钠调pH8~9,分出有机层,无水硫酸钠脱水,乙酸乙酯层用硫酸调pH5,过滤干燥得33g式I(R为苄基),收率61%。41g of compound 2 (R' is benzyl), 40g of N-benzyl tert-butylamine and 350mL of butanone were added to the reaction flask, heated under reflux for about 3 hours (whether the reaction was complete by thin-layer method, the method is the same as above), cooled and filtered to remove insolubles , recover butanone under reduced pressure, add 200 mL of ethyl acetate to the residue, extract with 1 mol/L hydrobromic acid for 2 to 3 times (the thin-layer method monitors whether the extraction is complete, the method is the same as above), 80 mL each time, and combine the acid water layers to obtain Aqueous hydrobromic acid solution of compound 4 (R is benzyl); 300 mL of ethyl acetate was added thereto, and the pH was adjusted to 8-9 with sodium carbonate under stirring, the organic layer was separated, dehydrated with anhydrous sodium sulfate, and the ethyl acetate layer was adjusted with sulfuric acid pH5, filtration and drying to obtain 33 g of formula I (R is benzyl) with a yield of 61%.

实施例11:制备硫酸特布他林Example 11: Preparation of Terbutaline Sulfate

将36.2g式I化合物(R=H)及90%乙醇540mL、1.8g10%Pd-C加入反应瓶中,排尽空气,通氢气常压氢化约20小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品26.8g,收率98%。36.2g of formula I compound (R=H), 540mL of 90% ethanol, 1.8g of 10% Pd-C were added to the reaction flask, the air was exhausted, and the hydrogen was hydrogenated at atmospheric pressure for about 20 hours (TLC monitoring until the hydrogenation reaction of the raw materials was complete, Silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add absolute ethanol to cool and crystallize, filter and dry to obtain sulfuric acid The crude product of terbutaline was 26.8 g, and the yield was 98%.

实施例12:制备硫酸特布他林Example 12: Preparation of Terbutaline Sulfate

将36.2g式I化合物(R=H)及80%乙醇450mL、1.6g10%Pd-C加入反应瓶中,排尽空气,通氢气常压氢化20小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品24.7g,收率90%。36.2g of the compound of formula I (R=H), 450mL of 80% ethanol, 1.6g of 10% Pd-C were added to the reaction flask, the air was exhausted, and the hydrogen was hydrogenated at atmospheric pressure for 20 hours (TLC was monitored until the hydrogenation reaction of the raw materials was complete, silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add absolute ethanol to cool and crystallize, filter and dry to obtain special sulfate. 24.7g crude butaline, the yield is 90%.

实施例13:制备硫酸特布他林Example 13: Preparation of Terbutaline Sulfate

将36.2g式I化合物(R=H)及90%乙醇540mL、1.1g10%Pd-C加入反应釜中,排尽空气,氢气压力0.15mpa氢化约10小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品25.2g,收率92%。36.2g of formula I compound (R=H) and 540mL of 90% ethanol, 1.1g of 10% Pd-C were added to the reactor, the air was exhausted, and the hydrogen pressure 0.15mpa was hydrogenated for about 10 hours (TLC monitoring until the raw material hydrogenation reaction was complete, Silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add absolute ethanol to cool and crystallize, filter and dry to obtain sulfuric acid The crude product of terbutaline was 25.2 g, and the yield was 92%.

实施例14:制备硫酸特布他林Example 14: Preparation of Terbutaline Sulfate

将36.2g式I化合物(R=H)及90%乙醇540mL、1.8g10%Pd-C加入反应瓶釜中,排尽空气,氢气压力0.2mpa氢化7小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品26.6g,收率98%。36.2g of formula I compound (R=H) and 540mL of 90% ethanol, 1.8g of 10% Pd-C were added to the reaction flask, the air was exhausted, and the hydrogen pressure 0.2mpa was hydrogenated for 7 hours (TLC was monitored until the hydrogenation reaction of the raw material was complete, Silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add absolute ethanol to cool and crystallize, filter and dry to obtain sulfuric acid The crude product of terbutaline was 26.6 g, and the yield was 98%.

实施例15:制备硫酸特布他林Example 15: Preparation of Terbutaline Sulfate

将36.2g式I(R=H)化合物及95%甲醇600mL、1.7g10%Pd-C加入反应瓶中,排尽空气,通氢气常压氢化约25小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品25.2g,收率92%。36.2g of the compound of formula I (R=H), 600mL of 95% methanol, 1.7g of 10% Pd-C were added to the reaction flask, the air was exhausted, and the hydrogen was hydrogenated at atmospheric pressure for about 25 hours (TLC monitoring until the hydrogenation reaction of the raw materials was complete, Silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add absolute ethanol to cool and crystallize, filter and dry to obtain sulfuric acid The crude product of terbutaline was 25.2 g, and the yield was 92%.

实施例16:制备硫酸特布他林Example 16: Preparation of Terbutaline Sulfate

将实施例10所得的33g式I化合物(R=苄基)及90%乙醇480mL、1.6g10%Pd-C加入反应瓶釜中,排尽空气,氢气压力0.2mpa氢化约7小时(TLC监控至原料氢化反应完全为止,硅胶GF254,展开剂:二氯甲烷-甲醇-三乙胺(10:2:1),紫外灯254nm显色),过滤,减压除去溶剂,加入无水乙醇冷却结晶,过滤干燥,得硫酸特布他林粗品15g,收率90%。33g of the compound of formula I (R=benzyl) obtained in Example 10, 480mL of 90% ethanol, 1.6g of 10% Pd-C were added to the reaction flask, the air was exhausted, and the hydrogen pressure 0.2mpa was hydrogenated for about 7 hours (TLC monitoring to The hydrogenation reaction of the raw materials is complete, silica gel GF 254 , developing solvent: dichloromethane-methanol-triethylamine (10:2:1), UV lamp 254nm color development), filter, remove the solvent under reduced pressure, add anhydrous ethanol to cool and crystallize , filtered and dried to obtain 15 g of crude terbutaline sulfate, with a yield of 90%.

实施例17:硫酸特布他林精制Example 17: Purification of Terbutaline Sulfate

将实施例11~16所得粗品50g及1500mL95%乙醇加入反应瓶,加热回流溶解,加入3g活性炭脱色20mins,过滤,滤液冷却结晶,得硫酸特布他林47.5g,收率95%,有关物质小于0.1%,HPLC结果见附图6。50g and 1500mL of 95% ethanol obtained in Examples 11-16 were added to the reaction flask, heated and refluxed to dissolve, 3g of activated carbon was added for decolorization for 20mins, filtered, and the filtrate was crystallized by cooling to obtain 47.5g of terbutaline sulfate, the yield was 95%, and the related substances were less than 0.1%, see Figure 6 for HPLC results.

实施例18:硫酸特布他林精制Example 18: Purification of Terbutaline Sulfate

将实施例11~16所得粗品50g及1000mL95%甲醇加入反应瓶,加热回流溶解,加入3g活性炭脱色20mins,过滤,滤液冷却结晶,得硫酸特布他林46.5g,收率93%,有关物质小于0.1%,HPLC结果见附图7。50g of the crude product and 1000mL of 95% methanol obtained in Examples 11-16 were added to the reaction flask, heated and refluxed to dissolve, 3g of activated carbon was added for decolorization for 20mins, filtered, and the filtrate was crystallized by cooling to obtain 46.5g of terbutaline sulfate, the yield was 93%, and the related substances were less than 0.1%, the HPLC results are shown in Figure 7.

实施例19:硫酸特布他林精制Example 19: Purification of Terbutaline Sulfate

将实施例11~16所得粗品50g及1100mL95%甲醇加入反应瓶,加热回流溶解,加入3g活性炭脱色20mins,过滤,滤液冷却结晶,得硫酸特布他林45g,收率90%,有关物质小于0.1%,HPLC结果见附图8。Add 50 g of the crude product obtained in Examples 11 to 16 and 1100 mL of 95% methanol into a reaction flask, heat under reflux to dissolve, add 3 g of activated carbon for decolorization for 20 mins, filter, and crystallize the filtrate by cooling to obtain 45 g of terbutaline sulfate, yield 90%, and related substances less than 0.1 %, and the HPLC results are shown in Figure 8.

Claims (10)

1.硫酸特布他林中间体,其特征在于:其结构式如式I所示:1. Terbutaline sulfate intermediate, is characterized in that: its structural formula is as shown in formula I:
Figure FDA0002471605120000011
Figure FDA0002471605120000011
其中,R为H或苄基。wherein R is H or benzyl.
2.权利要求1所述硫酸特布他林中间体的制备方法,其特征在于:合成路线如下:2. the preparation method of the described terbutaline sulfate intermediate of claim 1, is characterized in that: synthetic route is as follows:
Figure FDA0002471605120000012
Figure FDA0002471605120000012
其中,R’为乙酰基或苄基;当R’为乙酰基时,R为H,当R’为苄基时,R为苄基;Wherein, R' is acetyl or benzyl; When R' is acetyl, R is H, when R' is benzyl, R is benzyl; 包括以下步骤:Include the following steps: A、化合物1与溴素反应,得化合物2;A, compound 1 reacts with bromine to obtain compound 2; B、化合物2与化合物3反应,反应完毕,经回收溶剂后,得残余物;B, compound 2 reacts with compound 3, and the reaction is completed, and after recovering the solvent, a residue is obtained; 当R’为乙酰基时,残余物用盐酸或氢溴酸提取,酸水提取液经加热水解,冷却过滤干燥,得化合物4;When R' is an acetyl group, the residue is extracted with hydrochloric acid or hydrobromic acid, the acid water extract is hydrolyzed by heating, cooled, filtered and dried to obtain compound 4; 当R’为苄基时,残余物加入有机溶剂,然后用盐酸或氢溴酸提取,合并酸水层,得化合物4的水溶液;When R' is benzyl, the residue is added with an organic solvent, then extracted with hydrochloric acid or hydrobromic acid, and the aqueous acid layers are combined to obtain an aqueous solution of compound 4; C、将化合物4配成水和有机溶剂的混合溶液,加入碱碱化游离后,分得有机层,再向有机层加入硫酸成盐,得式I化合物。C. Compound 4 is made into a mixed solution of water and an organic solvent, and after alkali is added to make it free, an organic layer is obtained, and sulfuric acid is added to the organic layer to form a salt to obtain the compound of formula I.
3.根据权利要求2所述硫酸特布他林中间体的制备方法,其特征在于:步骤A中,化合物1与溴素的摩尔比为1:1~1.3。3. The preparation method of the terbutaline sulfate intermediate according to claim 2, characterized in that: in step A, the molar ratio of compound 1 to bromine is 1:1 to 1.3. 4.根据权利要求2所述硫酸特布他林中间体的制备方法,其特征在于:步骤A的具体操作为:将化合物1溶于二氯甲烷,向其中滴加少量溴素-二氯甲烷溶液引发反应,然后冷却至10℃以下继续滴加溴素-二氯甲烷液,滴加完毕后,反应液经水洗涤、浓缩,无水乙醇结晶,得化合物2。4. the preparation method of terbutaline sulfate intermediate according to claim 2, is characterized in that: the concrete operation of step A is: compound 1 is dissolved in dichloromethane, to wherein drip a small amount of bromine-dichloromethane The solution initiates the reaction, and then cooled to below 10° C. to continue adding the bromine-dichloromethane solution dropwise. After the dropwise addition, the reaction solution is washed with water, concentrated, and crystallized from anhydrous ethanol to obtain compound 2. 5.根据权利要求2所述硫酸特布他林中间体的制备方法,其特征在于:步骤B中,化合物2与化合物3的摩尔比1:2~3;化合物2与化合物3的反应条件为:以酮为溶剂,回流反应2~4h;所述酮为丁酮、2-戊酮、甲基异丙基甲酮或甲基叔丁基酮中的至少一种;优选为丁酮。5. The preparation method of the terbutaline sulfate intermediate according to claim 2, characterized in that: in step B, the molar ratio of compound 2 to compound 3 is 1:2 to 3; the reaction conditions of compound 2 and compound 3 are: : use ketone as solvent, and conduct reflux reaction for 2 to 4 hours; the ketone is at least one of butanone, 2-pentanone, methyl isopropyl ketone or methyl tert-butyl ketone; preferably butanone. 6.根据权利要求2所述硫酸特布他林中间体的制备方法,其特征在于:步骤B中,盐酸或氢溴酸的浓度为0.5mol~1.5mol/L,采用薄层法监控提取是否完全;当R’为乙酰基时,所述加热水解的条件为:30~60℃保温反应,水解终点采用薄层方法监控。6. the preparation method of terbutaline sulfate intermediate according to claim 2, is characterized in that: in step B, the concentration of hydrochloric acid or hydrobromic acid is 0.5mol~1.5mol/L, adopts thin layer method to monitor and extract whether Complete; when R' is an acetyl group, the conditions for the heating and hydrolysis are: 30-60° C. for the reaction, and the end point of the hydrolysis is monitored by a thin-layer method. 7.根据权利要求2~6任一项所述硫酸特布他林中间体的制备方法,其特征在于:步骤C中,碱化游离的条件为:加碱中和至反应液pH为8~9,所述碱为碳酸钠、碳酸钾、氢氧化钠或氢氧化钾;优选为碳酸钠或碳酸钾;硫酸成盐的条件为:硫酸调节有机层pH至5±0.2。7. according to the preparation method of the described terbutaline sulfate intermediate of any one of claim 2~6, it is characterized in that: in step C, the condition that alkalization is free is: adding alkali and neutralizing to reaction solution pH is 8~ 9. The alkali is sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide; preferably sodium carbonate or potassium carbonate; the conditions for sulfuric acid salification are: sulfuric acid adjusts the pH of the organic layer to 5±0.2. 8.利用权利要求2~7任一项方法制备所得硫酸特布他林中间体制备硫酸特布他林的方法,其特征在于:合成路线如下:8. Utilize any one method of claim 2~7 to prepare the method for gained terbutaline sulfate intermediate to prepare terbutaline sulfate, it is characterized in that: synthetic route is as follows:
Figure FDA0002471605120000021
Figure FDA0002471605120000021
其中,R为H或苄基;Wherein, R is H or benzyl; 包括以下步骤:以10%Pd/C为催化剂,醇水溶液为溶剂,通入H2,将式I硫酸特布他林中间体还原,得式II硫酸特布他林。The method comprises the following steps: using 10% Pd/C as a catalyst, an aqueous alcohol solution as a solvent, and introducing H 2 to reduce the intermediate of formula I terbutaline sulfate to obtain terbutaline sulfate of formula II.
9.根据权利要求8所述的制备硫酸特布他林的方法,其特征在于:至少满足下列一项:9. the method for preparing terbutaline sulfate according to claim 8 is characterized in that: at least the following one is satisfied: 式I化合物与10%Pd/C的质量比为1:0.02~0.1;优选为1:0.03~0.05;The mass ratio of the compound of formula I to 10% Pd/C is 1:0.02-0.1; preferably 1:0.03-0.05; 醇水溶液为含量50%~95%的甲醇水溶液或乙醇水溶液;优选为60%~90%的甲醇水溶液或乙醇水溶液;The alcohol aqueous solution is an aqueous methanol solution or an aqueous ethanol solution with a content of 50% to 95%; preferably an aqueous methanol solution or an aqueous ethanol solution of 60% to 90%; 式I化合物与醇水溶液的用量比为1g:10~20mL;优选为1g:15mL。The dosage ratio of the compound of formula I to the aqueous alcohol solution is 1 g: 10-20 mL; preferably, it is 1 g: 15 mL. 10.根据权利要求8或9所述的制备硫酸特布他林的方法,其特征在于:至少满足下列一项:10. The method for preparing terbutaline sulfate according to claim 8 or 9, characterized in that: at least one of the following is satisfied: 还原温度为15~50℃;优选为15~35℃;The reduction temperature is 15~50℃; preferably 15~35℃; 还原压力为常压~0.5Mpa;优选为常压~0.2Mpa。The reduction pressure is from normal pressure to 0.5Mpa; preferably from normal pressure to 0.2Mpa.
CN202010350331.3A 2020-04-28 2020-04-28 Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate using it Active CN111499528B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010350331.3A CN111499528B (en) 2020-04-28 2020-04-28 Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate using it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010350331.3A CN111499528B (en) 2020-04-28 2020-04-28 Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate using it

Publications (2)

Publication Number Publication Date
CN111499528A true CN111499528A (en) 2020-08-07
CN111499528B CN111499528B (en) 2023-06-20

Family

ID=71867864

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010350331.3A Active CN111499528B (en) 2020-04-28 2020-04-28 Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate using it

Country Status (1)

Country Link
CN (1) CN111499528B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115073313A (en) * 2022-08-24 2022-09-20 山东省食品药品检验研究院 Method for synthesizing terbutaline sulfate impurity C

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011258A (en) * 1973-06-21 1977-03-08 Aktiebolaget Draco Orally active bronchospasmolytic compounds
CN109305920A (en) * 2017-07-27 2019-02-05 海南利能康泰制药有限公司 A kind of preparation method of high-purity injection stage bricalin
CN111217691A (en) * 2018-11-26 2020-06-02 盈科瑞(天津)创新医药研究有限公司 Compound 1- (2-benzyl-3, 5-bis (benzyloxy) phenyl) ethanone, preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011258A (en) * 1973-06-21 1977-03-08 Aktiebolaget Draco Orally active bronchospasmolytic compounds
CN109305920A (en) * 2017-07-27 2019-02-05 海南利能康泰制药有限公司 A kind of preparation method of high-purity injection stage bricalin
CN111217691A (en) * 2018-11-26 2020-06-02 盈科瑞(天津)创新医药研究有限公司 Compound 1- (2-benzyl-3, 5-bis (benzyloxy) phenyl) ethanone, preparation method and application thereof
WO2020107913A1 (en) * 2018-11-26 2020-06-04 盈科瑞(天津)创新医药研究有限公司 Compound or salt thereof, preparation method and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张艳青: "CAS:52144-93-1, 94109-62-3", 《STN REGISTRY DATABASE》 *
张雪利等: "叔丁喘宁的合成工艺改进", 《深圳大学学报(理工版)》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115073313A (en) * 2022-08-24 2022-09-20 山东省食品药品检验研究院 Method for synthesizing terbutaline sulfate impurity C
CN115073313B (en) * 2022-08-24 2022-11-25 山东省食品药品检验研究院 Method for synthesizing terbutaline sulfate impurity C

Also Published As

Publication number Publication date
CN111499528B (en) 2023-06-20

Similar Documents

Publication Publication Date Title
CN102395561A (en) Processes for the synthesis of bazedoxifene acetate and intermediates thereof
CN110818610A (en) Method for preparing melatonin
CN112062767A (en) A kind of preparation method of lumepirone and intermediate thereof
CN103113240B (en) Process for directly synthesizing p-aminophenol through hydrogenation of nitrobenzene
CN114605275A (en) Novel synthesis method of dopamine without bromine hydrochloride
CN111499528B (en) Terbutaline sulfate intermediate, preparation method thereof and method for preparing terbutaline sulfate using it
CN103012268B (en) Novel preparation method for ivabradine
CN106380438A (en) Preparation method of indoline derivative for synthesizing silodosin
CN102050748B (en) Method for preparing expectorant, namely ambroxol key intermediate trans-4-[(2-amino benzyl) amino]-cyclohexanol
CN107382753B (en) Preparation method of high-purity ritodrine hydrochloride
CN102229537B (en) Method for synthesizing citric acid diphenhydramine
CN110105222A (en) A kind of novel processing step of 4- aminoidan class compound
CN117105884A (en) Preparation method of 1- (2-aminoethyl) pyrrolidine
CN104803861A (en) Method for synthesizing tapentadol hydrochloride
WO2020010765A1 (en) Method for synthesizing terbutaline intermediate
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN115557891A (en) Preparation method of dextromethorphan
CN102363598B (en) Method for preparing high-purity gabapentin
CN114516817A (en) Chemical intermediate and preparation method thereof
CN114736210A (en) Preparation method of a crystal form of morphinan derivative
CN118812411A (en) A method for preparing 5-aminolevulinic acid hydrochloride intermediate
CN114605241B (en) Preparation method of esketamine hydrochloride intermediate and intermediate thereof
CN101066936B (en) Refining process of ethyl dihydrazone
CN114736146A (en) Preparation method of novel 1-methylpyrrolidine-2-acrylic acid
CN114507184A (en) Synthesis method and application of 1-methylhexahydroazepin-4-one hydrochloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20251103

Address after: 610000 No. 631 Yanhua Road, Sichuan Dujiangyan Economic Development Zone, Chengdu City, Sichuan Province

Patentee after: Chengdu Lier Pharmaceutical Co.,Ltd.

Country or region after: China

Address before: 610041 Sichuan Province, Chengdu City, Fangcao Street No. 23

Patentee before: Chengdu ruiteen Technology Co.,Ltd.

Country or region before: China

TR01 Transfer of patent right